Company: SVV
Filing Date: 2025-05-16
Form Type: 424B5
Source: 0001193125-25-121233
Chunk: 10

Company: Savers Value Village, Inc.
Filing Date: 2025-05-16
Form: 424B5
Chunk 10
---
 and is not incorporated by reference into this prospectus supplement or the accompanying prospectus, and you should not consider information on our website to be
part of this prospectus supplement and the accompanying prospectus.

S-3

THE OFFERING

| Common stock offered by the selling stockholders | 15,000,000 shares (or 17,250,000 shares if the underwriters exercise their option to purchase additional shares in full as described below). |

| Concurrent Share Repurchase | Subject to the completion of this offering, we intend to purchase from the underwriters 2,258,132 shares of our common stock at a price per share equal to the price per share to be paid by the underwriters to the selling stockholders. |

The terms and conditions of the Concurrent Share Repurchase were reviewed and approved by an independent committee of our board of directors, with the input of independent counsel. The Concurrent Share Repurchase will be funded from our existing cash on hand and is not part of our existing share repurchase program authorized on November 9, 2023. The underwriters will not receive any compensation for the shares being repurchased by us in the Concurrent Share Repurchase. See “Concurrent Share Repurchase.”

| Common stock to be outstanding after this offering and the Concurrent Share Repurchase | 155,183,831 shares |

| Option to purchase additional shares of common stock | The Ares selling stockholders have granted the underwriters the right to purchase an additional 2,250,000 shares of common stock within 30 days from the date of this prospectus supplement. |

| Use of proceeds | The selling stockholders are offering all of the shares of our common stock being sold in this offering, including any shares that may be sold in connection with the exercise of the underwriters’ option to purchase additional shares, and             
 will receive all of the proceeds from the sale of shares of our common stock in this offering. We are not selling any shares of our common stock in this offering and we will not receive any proceeds from the sale of shares of our common stock by the 
 selling stockholders in this offering.                                                                                                                                                                                                                    |

| The Registration Rights Agreement (as defined below) sets forth our obligation to reimburse certain expenses that are incurred by the Ares selling stockholders. The selling stockholders will pay any underwriting 
 discounts, selling commissions and stock transfer taxes applicable to the sale of the shares of common stock. We will pay all remaining fees, costs and expenses.                                                   |

| Voting rights | One vote per